Table 1 Baseline characteristics of the study cohort (n = 111)
No of subjects (%) mean ± SD | |
|---|---|
Age (years) | 62,9 ± 9,6 |
Heart rate (strokes/minute) | 63 ± 7,4 |
BMI (kg/m2) | 26 ± 3,6 |
Male sex | 82 (74,0) |
Total cholesterol (mmol/L) | 4,9 ± 1,1 |
Blood pressure (mm Hg) | |
Systolic | 141 ± 20 |
Diastolic | 82 ± 12 |
Medical history | |
Hypertension (>140/90 mm Hg) | 61 (55,0) |
Current smoking | 29 (26,1) |
Diabetes | 11 (9,9) |
Previous CAD | 24 (21,6) |
ACS | 35 (31,5) |
Cardiac medication | |
Aspirin | 98 (88,3) |
Thienopyridine | 38 (34,2) |
Low-molecular-weight heparin | 30 (27,0) |
β-Blockers | 87 (78,4) |
Statins | 89 (80,2) |
Calcium antagonists | 21 (18,9) |
ACE-inhibitors/ARB | 25 (22,5) |
Organic nitrate, daily maintenance | 13 (11,7) |